State Street Technology Select Sector SPDR ETF (XLK) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Sector/ThematicSector
- $198.2152W High
- $127.4952W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track State Street Technology Select Sector SPDR ETF (XLK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, State Street Technology Select Sector SPDR ETF has traded between a low of $127.49 and a high of $198.21, highlighting its annual price range. Buy and sell State Street Technology Select Sector SPDR ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About State Street Technology Select Sector SPDR ETF
XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Most Recent News
Nutex Health hit by ransomware; patient and employee data stolen and threatened for release
Nutex Health, a micro-hospital operator, suffered a ransomware attack by The Gentlemen group, which accessed and stole confidential patient, employee, and business data. The attackers threatened to publish the stolen information, increasing risks of ...
Oil prices rise over 2% amid escalating US-Iran tensions and attacks in the Middle East
Oil prices surged as tensions in the Middle East escalated following recent US strikes on Iran and retaliatory attacks by Iran on US allies Kuwait, Jordan, and Bahrain. Brent crude futures rose over 2% to $96.59 a barrel, while US West Texas Intermed...
Alumis stock plunges 57% after lupus drug trial fails, but psoriasis drug progress continues.
Alumis' stock dropped 56.58% after its Phase II lupus drug trial failed to meet main goals, causing a significant market reaction. However, positive results in a subgroup of lupus patients with a high interferon gene signature offer a potential path ...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.